Skip to main content

Overview


Enthusiastic, determined, and hard-working. I am a PhD candidate in pharmacology and cancer biology and affiliated with the cellular and molecular biology (CMB) umbrella program at Duke University School of Medicine. My thesis work is titled "Identifying novel downstream targets of dysregulated Hippo signaling in fusion-positive rhabdomyosarcoma". 


Outside of the lab I participate in mentorship, outreach, and science communication alongside private organizations and personal social media marketing.

In the News


Published October 11, 2019
Rainbow Breakfast Shines Light on CCSU LGBTQ Achievements
Published February 24, 2018
BMS students present at NEURON
Published December 1, 2016
Studying Bio In The Midwest: Elizabeth Mendes

View All News

Recent Publications


Abstract 1092: RUNX2 inhibition alters PAX3::FOXO1 driven fusion-positive rhabdomyosarcoma cell state and growth

Conference Cancer Research · March 22, 2024 AbstractInvestigation: Fusion-positive rhabdomyosarcoma (FP-RMS) is an aggressive pediatric cancer of skeletal muscle lineage. While the incidence of RMS is ~4.5 patients per million individuals aged &lt ... Full text Cite
View All Publications